Global Pruritus Therapeutics Market Emerging Industry Trends & Global Future Forecasts 2020-2026
Pruritus, also known as itching, is a common symptom of various skin conditions, allergic reactions, systemic diseases and psychological disorders. It can affect the quality of life and well-being of patients and lead to secondary complications such as infections, scars and sleep disturbances. The global pruritus therapeutics market is expected to grow at a significant rate during the forecast period of 2020-2026, owing to the rising prevalence of pruritus, increasing awareness and demand for effective treatments, and the development of novel drugs and therapies.
The global pruritus therapeutics market was valued at USD XX billion in 2019 and is projected to reach USD XX billion by 2026, registering a CAGR of XX% during the forecast period. The market is segmented by type, treatment, end-user and region.
Based on type, the market is classified into chronic pruritus and acute pruritus. Chronic pruritus is defined as itching that lasts for more than six weeks and is often associated with chronic skin conditions such as atopic dermatitis, psoriasis, lichen planus and urticaria. Acute pruritus is defined as itching that lasts for less than six weeks and is usually caused by transient factors such as insect bites, contact dermatitis, drug reactions and infections. The chronic pruritus segment accounted for the largest share of the market in 2019 and is expected to maintain its dominance during the forecast period. This is attributed to the high prevalence of chronic pruritus among the elderly population, the increasing incidence of chronic skin diseases and the availability of various treatment options.
Based on treatment, the market is divided into topical therapy, systemic therapy and others. Topical therapy includes creams, lotions, gels, ointments and sprays that contain anti-inflammatory, antihistamine, antipruritic or moisturizing agents. Systemic therapy includes oral or injectable drugs that act on the central nervous system or the immune system to reduce itching. Others include phototherapy, acupuncture, psychotherapy and alternative medicine. The topical therapy segment held the largest share of the market in 2019 and is expected to grow at a steady rate during the forecast period. This is due to the easy availability, low cost and minimal side effects of topical products. However, the systemic therapy segment is anticipated to witness the fastest growth rate during the forecast period. This is owing to the development of novel drugs such as biologics and immunomodulators that target specific pathways involved in pruritus.
Based on end-user, the market is categorized into hospitals & clinics, home care settings and others. The hospitals & clinics segment dominated the market in 2019 and is expected to retain its lead during the forecast period. This is because most patients with severe or persistent pruritus seek professional medical advice and treatment from hospitals & clinics. Moreover, hospitals & clinics offer advanced diagnostic tools and therapeutic options for pruritus patients. The home care settings segment is projected to grow at a significant rate during the forecast period. This is due to the increasing preference of patients for self-care and home-based treatments that are convenient and cost-effective.
Based on region, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA. North America accounted for the largest share of the market in 2019 and is expected to maintain its dominance during the forecast period. This is attributed to the high prevalence of pruritus in this region, especially among the geriatric population. Moreover, North America has a well-established healthcare infrastructure and a high adoption rate of novel drugs and therapies for pruritus. Europe held the second-largest share of the market in 2019 and is expected to witness a steady growth rate during the forecast period. This is due to the increasing awareness and aa16f39245